Huiyu Pharmaceutical: Net profit loss of 24.2 million yuan in 2025.

Huiyu Pharmaceutical released its interim report, achieving a total operating income of 998 million yuan in 2025, a year-on-year decrease of 8.79%; a net loss of 24.2 million yuan, compared to a net profit of 325 million yuan in the same period last year. During the reporting period, the centralized procurement policy continued to deepen, and the company actively implemented the national centralized volume procurement policy, resulting in a decrease in product prices and profits, impacting the company's performance.